for people with uncontrolled type 2 diabetes
A GAME CHANGER. A LIFE CHANGER.
Unprecedented
HbA1c reduction
HbA1c reduction
Up to 1.5%
reduction in HbA1c*7
reduction in HbA1c*7
Unsurpassed
weight loss
weight loss
Up to 5kg
weight loss^9
weight loss^9
Unveil the benefits of Rybelsus®>>>
Not a real patient. The images of person depicted are for illustration purposes only. Not a real case profile, depicted profile is for hypothetical purposes only
Abbreviations: T2DM: Type 2 diabetes Mellitus, HbA1c: Glycated hemoglobin, CVD: Cardiovascular Disease, MACE: Major Adverse Cardiovascular Events
*Baseline HbA1c of 8.0%, ^Baseline weight - 92.9 kg
Abbreviations: T2DM: Type 2 diabetes Mellitus, HbA1c: Glycated hemoglobin, CVD: Cardiovascular Disease, MACE: Major Adverse Cardiovascular Events
*Baseline HbA1c of 8.0%, ^Baseline weight - 92.9 kg
for people with uncontrolled type 2 diabetes
A GAME CHANGER. A LIFE CHANGER.
Benefits of adding oral semaglutide in PwDs on insulin15
1.2%
Additional
HbA1c reduction
of 1.2%*15
HbA1c reduction
of 1.2%*15
4.2 kg
No weight gain
and weight loss
of 4.2 kg^15
and weight loss
of 4.2 kg^15
20%
Insulin sparing
effect - reduction
of total daily
insulin dose15
effect - reduction
of total daily
insulin dose15
Low risk of
severe hypoglycemic
episodes compared
to placebo15
severe hypoglycemic
episodes compared
to placebo15
*Baseline HbA1c: 8.2%, ^Baseline weight: 85.9 kg
Abbreviation: HbA1c: glycated haemoglobin, PwDs: People with diabetes
Abbreviation: HbA1c: glycated haemoglobin, PwDs: People with diabetes
